- Home
- PRDO vs TVTX Comparison
PRDO vs TVTX Comparison
Compare PRDO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRDO
- TVTX
- Stock Information
- Founded
- PRDO 1994
- TVTX 2008
- Country
- PRDO United States
- TVTX United States
- Employees
- PRDO N/A
- TVTX N/A
- Industry
- PRDO Other Consumer Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRDO Real Estate
- TVTX Health Care
- Exchange
- PRDO Nasdaq
- TVTX Nasdaq
- Market Cap
- PRDO 1.8B
- TVTX 1.5B
- IPO Year
- PRDO N/A
- TVTX N/A
- Fundamental
- Price
- PRDO $27.94
- TVTX $19.46
- Analyst Decision
- PRDO Buy
- TVTX Buy
- Analyst Count
- PRDO 1
- TVTX 12
- Target Price
- PRDO $32.00
- TVTX $24.58
- AVG Volume (30 Days)
- PRDO 462.5K
- TVTX 1.2M
- Earning Date
- PRDO 02-19-2025
- TVTX 02-13-2025
- Dividend Yield
- PRDO 1.72%
- TVTX N/A
- EPS Growth
- PRDO N/A
- TVTX N/A
- EPS
- PRDO 1.99
- TVTX N/A
- Revenue
- PRDO $652,751,000.00
- TVTX $203,447,000.00
- Revenue This Year
- PRDO N/A
- TVTX $62.37
- Revenue Next Year
- PRDO $2.27
- TVTX $61.74
- P/E Ratio
- PRDO $14.02
- TVTX N/A
- Revenue Growth
- PRDO N/A
- TVTX 57.08
- 52 Week Low
- PRDO $16.12
- TVTX $5.12
- 52 Week High
- PRDO $29.47
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- PRDO 63.84
- TVTX 59.31
- Support Level
- PRDO $25.48
- TVTX $16.80
- Resistance Level
- PRDO $26.63
- TVTX $18.76
- Average True Range (ATR)
- PRDO 0.61
- TVTX 0.95
- MACD
- PRDO 0.16
- TVTX 0.09
- Stochastic Oscillator
- PRDO 91.31
- TVTX 89.86
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segment include the American InterContinental University, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services with majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.